Managing Director

Managing Director

Amsterdam

B2B, Industrie

Digital, Consulting Exit, General Management

Publicatie: 13 februari 2018

Over the last 20 years, Eurofins has been the best performing share in Europe. As a result of its ambitious buy-and-build strategy, there is an opportunity for a new Managing Director for two of Eurofins’ Dutch entities (total of 70 FTE): a recent acquisition in Rotterdam and an existing business in Amsterdam.

Leading Innovation

We live in an age of rapid disruption. Today’s best-in-class is tomorrow’s out-of-date. This is why Eurofins continuously focuses on innovation. Both in terms of science and business.

Each of the Eurofins’ laboratories operates as a dynamic, market-driven business in its own right, managed by its own independent entrepreneurial leader, constantly striving for improvement. The people are empowered, not micro-managed. They’re not afraid to take risks or do things differently. Because world-class results don’t happen by accident. They require focus, top of the range resources and a concentration of brilliant minds who are highly motivated to push the boundaries and deliver the very best outcomes.

“At Eurofins, it is never business as usual. This atypical approach requires atypical people. Entrepreneurs with a passion for life sciences, a knack for collaboration and a strong business instinct.” – Frederic Dupont, Business Line Director

Eurofins’ leaders are as comfortable with the high-tech side of science as they are building the business. They thrive on the freedom to make their own decisions, but understand the importance of teamwork. Eurofins is a collaboration of entrepreneurs, who understand they are stronger together. This decentralized approach works because Eurofins has complete confidence in the judgment and competence of its leaders.

Vision

To be world leader in food, environment and pharmaceutical products testing. In short: ‘Testing for Life’.

Mission

To contribute to a safer and healthier world for all, by providing clients across many industries with high quality laboratory and advisory services, whilst creating opportunities for employees and generating sustainable shareholder value.

Strategy

Eurofins operates an ambitious buy-and-build strategy to meet market demand, both acquiring successful labs and creating start-ups from scratch. As such, Eurofins is a global hub, empowering independent companies led by strong entrepreneurs.

Results

Since its IPO on Euronext Paris in 1997, Eurofins has consistently been the best performing share in Europe, with a CAGR of 33%.

Eurofins in numbers

  • 1987 – The company was founded in France, and purchased SNIF-NMR® – a method to detect whether sugar has been added to wine.
  • 35.000 – Employees around the world, combining scientific excellence with commercial awareness.
  • 400.000 m3 – Of laboratory surface, or 400 laboratories across six continents.
  • Together, they perform 230 million tests every month.
  • €3 Billion – Annualized revenues in 2017. In 2012, Eurofins set the target to double its revenues to €2 billion in just five years. They hit this two years early, and they are on target to achieve a turnover of €4 billion by 2019
  • 290 – The share price multiplied 290 times between the IPO in 1997 and October 2017. With an average annual increase of 33%, they are the best performing share in Europe.

“The international scope, unadulterated growth ambitions and ruthlessly entrepreneurial culture make Eurofins a magnificent environment for outperformers. If you’re looking for an opportunity to prove yourself, it doesn’t get any better than this.” – Frederic Dupont, Business Line Director

Managing Director

As a result of Eurofins’ ambitious buy-and-build strategy, an opportunity has come up at Managing Director level. This leader will be responsible for the integration, organic growth and commercial success of two of Eurofins’ Dutch entities: a recent acquisition in Rotterdam and an existing business in Amsterdam.

The Managing Director will develop a strategic plan for the merger and ensuing growth of the market share. The first phase of the plan will consist of challenging, achievable and fact-based milestones for the integration the acquisition within Eurofins, The Managing Director will leverage synergies by aligning processes, policies and regulations. The next stage will be to achieve significant organic growth and to increase profitability. A strong focus on operational excellence is key.

The new entity will be market leader in asbestos testing, a highly competitive, low-margin industry. The Managing Director will always stay up to date with the state of the market. This is crucial in order to lead the organization in terms of marketing, sales and pricing. The Managing Director will report to Frederic Dupont, the Business Line Director.

“Growing our business profitably, that is what we do. Every sizeable opportunity – organic or inorganic – will be taken into consideration.” – Frederic Dupont

What all Eurofins’ leaders have in common, is that they combine an excellent academic track record and strong analytical skills with a ruthlessly ambitious, results-driven mindset and extremely high levels of energy. They typically have had prior P&L-responsibility which is testimony to their superior business acumen, but the emphasis is on potential rather than experience. The bar is high.

“It’s our explicit strategy to hire the best, most-qualified leaders for our businesses, and empower them with vast entrepreneurial freedom.” – Frederic Dupont

Eurofins has partnered up with Top of Minds to find the perfect candidate for this role. For more information or to apply, contact Roland Vetten, Partner at Top of Minds, via roland@topofminds.com

Recruiter Top of Minds Amsterdam

Roland Vetten

Partner

Solliciteer

Sollicitatie (mobile)

Inspirerend interview

Managing Director

Over the last 20 years, Eurofins has been the best performing share in Europe. As a result of its ambitious buy-and-build strategy, there is an opportunity for a new Managing Director for two of Eurofins’ Dutch entities (total of 70 FTE): a recent acqu …

Lees meer